Product Datasheet
|
|
|
Product Description |
|
Product: |
IgA1, Human Myeloma Plasma |
Catalog Number: |
HU-IGA1M |
Product Page: |
https://www.mol-innov.com/products/IHUIGA1MYAP5MG |
Description: |
In normal adult serum, the approximate percentage composition of IgA with respect to is subclasses is IgA1:90percent and IgA2:10percent. In secretory IgA, the subclass proportions may approach 50:50. The clinical significance of the subclasses has yet to be determined. No reaction by IEP to IgA2 antiserum. Prepared from myeloma plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests. >95percent pure by SDS-PAGE. |
Recommended Storage: |
SAMPLE |
Minimum Shelf Life: |
275.50 |
Source: |
1.0 mg/ml |
Molecular Weight: |
Proteins |
Extinction Coefficient: |
160,000 |
Antigen: |
-70 C |
Target: |
Frozen liquid |
Target Molecular Weight: |
HUMAN IMMUNOGLOBULINS |
Host: |
418 |
Clonality: |
5 |
Isotype: |
Human myeloma plasma |
Clone: |
s |
Applications: |
Dry ice |
Cross-reactivity: |
3 years from delivery |
Concentration: |
290 |
Volume: |
440 |
Specific activity: |
SodiumAzide |
Titer: |
0.01M Sodium Phosphate; 0.15M NaCl; 0.05% Sodium Azide; pH7.4 |
Buffer: |
SAMPLE |
Form: |
5.0 mg |
Preservative: |
5.0 ml |
|
Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet. |
|
For in vitro laboratory use only |
|
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com |